3Sugiyama M, Kodama T, Konishi K, et al. Compaetin and simvastatin, but not pravastatin, induce bone morphogenetic protein 2 in human osteosarcoma ceils[J]. B iochem Biophys Res C ommun ,2000 ;271 (3) :688-92.
4Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated Kinase in human osteoboasta[J]. Biochem Biophys Res Commun ,2001 ;287 ( 2 ) :337-42.
6Waldman A, Kritharides L .The pleiotropie effects of HMG-CoA reduetase inhibitors ; their role in osteoporosis and dementia [J]. Drugs, 2003 ; 63 (2) :139-52.
二级参考文献49
1Owen TA, Aronow M, Shalhoub V, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracelluar
2Luckman SP, Hughes D E, Coxon FP, et al.Nitrogen- containing bisphosphonates inhibit the mevalonate pathway and prevent post - translational prenylation of GTP - binding proteins, including Ras.J Bone Miner Res, 1998, 13(4) :581 ～ 589
3Fisher JE, Rogers MJ, Halasy JM, et al. Alendronate mechamsm of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci, 1999,96(1
4Rogers M J, Xiong X, Brown RJ et al. Structure - activity relationships of new heterocycle - containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae. Mol. Phamacol, 1995, 47(2) :398～ 402
5Nakamura Y. Koshiyama H. Wada Y, et al. Lack of positive correlation between statin use and bore mineral density in Japanese subjects with tpye diavetes. Arch Intern Med, 2000, 160:2865
6Ohnaka K, Shimoda S, Nawata H. et al. Pitavastatin enhanced BMP - 2 and osteecalcin expression by inhibition of Rho - associated kinase in human osteoblasts. Iochem Biophys Res Commun, 2001, 21,287(2): 337 - 342
7Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids receiving steroids. Clin Orthop, 2001,386:173 - 178
8Cui Q, Wang GJ, Su CC, et al.The Otto Aufrance Award. Lovastatin prevents steroid indeuced adipogenesis and osteonecrosis. Clin Orthop, 1997,334: 8- 19
9Meier CR, Schlienger RG, Kraenzlin ME. et al. HMG CoA reductase inhibitors and the risk of fractures JA MA, 2000, 283: 3205 - 3210
10Chang YS, Lee MD, Lee SK , et al. HMG- CoA reducase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab, 2000, 85(3):1137- 1142
